TABLE 2

Carotid IMT and characteristics of type 2 diabetic patients with and without adiponectinuria and albuminuria

1 Adiponectinuria (−) Albuminuria (−)2 Adiponectinuria (+) Albuminuria (−)3 Albuminuria (+)
n432192
Age (years)60.8 ± 8.961.4 ± 7.160.7 ± 7.0
Sex (male)33 (76.7)14 (66.7)71 (77.2)
BMI (kg/m2)32.3 ± 5.032.7 ± 6.633.6 ± 6.4
FPG (mmol/l)7.08 ± 1.556.94 ± 2.678.67 ± 2.97*
A1C (%)6.9 ± 0.87.2 ± 1.67.4 ± 1.2
Creatinine clearance (ml/min)111.5 ± 46.2109.1 ± 29.5107.9 ± 41.0
Serum adiponectin (μg/ml)10.6 ± 7.411.4 ± 6.110.0 ± 6.7
Duration of diabetes (years)10.0 (5.0–13.0)9.5 (5.8–17.3)13.6 (7.0–18.6)§
Carotid IMT (mm)0.84 ± 0.140.95 ± 0.100.89 ± 0.15§
  • Data are means ± SD, n (%), or median (interquartile range). Adiponectinuria is defined as adiponectin excretion >mean + 2 SD (95th percentile) of control urinary adiponectin excretion. Albuminuria is defined as AER >30 mg/24 h.

  • *P < 0.01 for group 3 group 2;

  • P < 0.05 for group 3 vs. group 1 (by independent t test or Mann-Whitney U test);

  • §P < 0.05;

  • P < 0.001 for group 2 vs. group 1.